PERJETA - Pertuzumab
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-145 |
| Proprietary Name: | PERJETA |
| Suffix: | |
| Non-Proprietary Name: | Pertuzumab |
| Dosage Form: | INJECTION, SOLUTION, CONCENTRATE |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 08-06-2012 |
| Category Name: | BLA |
| Application Number: | BLA125409 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | PERTUZUMAB |
| Active Numerator Strength: | 30 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] |
| DEA Schedule: |